There are no in-principle ethical objections to controlled voluntary SARS-CoV-2 infection
In response to the COVID-19 pandemic, some authors have advocated a program of controlled voluntary infection (CVI) with SARS-CoV-2. Under CVI, during periods where the medical system is under capacity, volunteers from low-risk groups would be intentionally infected after giving informed consent, an...
| Main Author: | |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Journals Online & Print: | Drawer...
|
| Fernleihe: | Fernleihe für die Fachinformationsdienste |
| Published: |
Wiley-Blackwell
[2021]
|
| In: |
Bioethics
Year: 2021, Volume: 35, Issue: 3, Pages: 237-245 |
| IxTheo Classification: | NCH Medical ethics |
| Further subjects: | B
controlled voluntary infection
B Informed Consent B no choice situations B Severe acute respiratory syndrome-related coronavirus 2 B Covid-19 B reasonable beneficence B Medical Ethics |
| Online Access: |
Presumably Free Access Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
MARC
| LEADER | 00000caa a22000002 4500 | ||
|---|---|---|---|
| 001 | 1750568594 | ||
| 003 | DE-627 | ||
| 005 | 20240826222729.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210305s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/bioe.12835 |2 doi | |
| 035 | |a (DE-627)1750568594 | ||
| 035 | |a (DE-599)KXP1750568594 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 1 |2 ssgn | ||
| 100 | 1 | |a Crummett, Dustin |e VerfasserIn |0 (orcid)0000-0003-1508-1184 |4 aut | |
| 109 | |a Crummett, Dustin | ||
| 245 | 1 | 0 | |a There are no in-principle ethical objections to controlled voluntary SARS-CoV-2 infection |
| 264 | 1 | |c [2021] | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a In response to the COVID-19 pandemic, some authors have advocated a program of controlled voluntary infection (CVI) with SARS-CoV-2. Under CVI, during periods where the medical system is under capacity, volunteers from low-risk groups would be intentionally infected after giving informed consent, and then quarantined until they have developed immunity. Proponents claim that this could have benefits for society, such as building herd immunity and ensuring that critical workers won’t be incapacitated during the peak of the infection. They also claim that this could have benefits for individuals, such as being safely exempted from lockdown measures and (for individuals who are likely to be infected anyway) ensuring that the infection happens under relatively less dangerous conditions. Some respond that CVI would unethical. Here, I argue that, while CVI may or may not be ill-advised for empirical reasons, there are no in-principle ethical objections to it (i.e., if CVI would work as well as its proponents think, it would be ethical to implement it). I present three arguments for this conclusion. The first is an argument from informed consent: informed consent to relevantly similar medical procedures renders performing these procedures permissible, so informed consent to CVI would render it permissible. The second is an argument from reasonable beneficence: it draws on recent work by Caspar Hare on relevantly similar choices to argue that CVI is permissible. The third is an argument from precedent: smallpox variolation was permissible, and CVI is relevantly similar to that, so CVI is permissible. | ||
| 601 | |a Controlling | ||
| 601 | |a SARS-CoV-2 | ||
| 650 | 4 | |a Covid-19 | |
| 650 | 4 | |a SARS-CoV-2 | |
| 650 | 4 | |a controlled voluntary infection | |
| 650 | 4 | |a Informed Consent | |
| 650 | 4 | |a Medical Ethics | |
| 650 | 4 | |a no choice situations | |
| 650 | 4 | |a reasonable beneficence | |
| 652 | |a NCH | ||
| 773 | 0 | 8 | |i Enthalten in |t Bioethics |d Oxford [u.a.] : Wiley-Blackwell, 1987 |g 35(2021), 3, Seite 237-245 |h Online-Ressource |w (DE-627)271596708 |w (DE-600)1480658-7 |w (DE-576)078707986 |x 1467-8519 |7 nnns |
| 773 | 1 | 8 | |g volume:35 |g year:2021 |g number:3 |g pages:237-245 |
| 856 | |u https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bioe.12835 |x unpaywall |z Vermutlich kostenfreier Zugang |h publisher [open (via crossref license)] | ||
| 856 | 4 | 0 | |u https://doi.org/10.1111/bioe.12835 |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://onlinelibrary.wiley.com/doi/abs/10.1111/bioe.12835 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| ELC | |a 1 | ||
| ITA | |a 1 |t 1 | ||
| LOK | |0 000 xxxxxcx a22 zn 4500 | ||
| LOK | |0 001 3882290307 | ||
| LOK | |0 003 DE-627 | ||
| LOK | |0 004 1750568594 | ||
| LOK | |0 005 20211006153656 | ||
| LOK | |0 008 210305||||||||||||||||ger||||||| | ||
| LOK | |0 040 |a DE-Tue135 |c DE-627 |d DE-Tue135 | ||
| LOK | |0 092 |o n | ||
| LOK | |0 852 |a DE-Tue135 | ||
| LOK | |0 852 1 |9 00 | ||
| LOK | |0 935 |a ixzs |a ixzo | ||
| LOK | |0 936ln |0 1550736558 |a NCH | ||
| OAS | |a 1 | ||
| ORI | |a TA-MARC-ixtheoa001.raw | ||
| STA | 0 | 0 | |a Severe acute respiratory syndrome-related coronavirus 2 |
| STB | 0 | 0 | |a SARS-CoV-2 (virus) |
| STC | 0 | 0 | |a SARS-CoV-2 |
| STD | 0 | 0 | |a SARS-CoV-2,SARS-CoV-2 |
| STF | 0 | 0 | |a 嚴重急性呼吸綜合症冠狀病毒2型 |
| STG | 0 | 0 | |a Coronavírus da síndrome respiratória aguda grave 2 |
| STH | 0 | 0 | |a SARS-CoV-2 |
| STI | 0 | 0 | |a SARS-CoV-2 |
| SYE | 0 | 0 | |a Schweres akutes Atemwegssyndrom Coronavirus 2,Severe acute respiratory syndrome coronavirus 2,2019-nCoV,2019-novel Corona virus,Wuhan-Coronavirus |